| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 190.589 | - | - | 66.606 | 79.036 | 86.035 | 67.442 | 108.332 | 126.176 | 276.897 |
| Total Income - EUR | 195.110 | - | - | 75.311 | 79.043 | 89.450 | 67.447 | 116.458 | 130.695 | 281.950 |
| Total Expenses - EUR | 193.869 | - | - | 72.645 | 72.611 | 85.662 | 62.854 | 98.834 | 119.610 | 270.800 |
| Gross Profit/Loss - EUR | 1.241 | - | - | 2.666 | 6.432 | 3.789 | 4.593 | 17.624 | 11.085 | 11.151 |
| Net Profit/Loss - EUR | 843 | - | - | 1.912 | 5.648 | 2.983 | 3.999 | 16.658 | 10.034 | 4.631 |
| Employees | 6 | - | - | 5 | 4 | 4 | 3 | 2 | 2 | 3 |
Check the financial reports for the company - Remed Prodimpex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 122.419 | - | - | 108.939 | 104.631 | 102.376 | 132.970 | 129.126 | 124.104 | 58.071 |
| Current Assets | 181.751 | - | - | 71.034 | 43.635 | 53.509 | 72.901 | 71.212 | 73.553 | 131.340 |
| Inventories | 11.077 | - | - | 1.631 | 890 | 1.386 | 4.854 | 2.701 | 9.949 | 11.611 |
| Receivables | 143.718 | - | - | 57.168 | 23.919 | 29.900 | 56.268 | 44.543 | 25.170 | 25.780 |
| Cash | 26.956 | - | - | 12.235 | 18.826 | 22.223 | 11.780 | 23.967 | 38.435 | 93.949 |
| Shareholders Funds | 146.848 | - | - | 140.973 | 127.192 | 119.059 | 120.417 | 137.449 | 145.372 | 147.003 |
| Social Capital | 14.063 | - | - | 13.433 | 13.173 | 12.923 | 12.636 | 12.676 | 12.637 | 12.567 |
| Debts | 68.481 | - | - | 39.133 | 21.683 | 30.747 | 76.478 | 59.998 | 53.223 | 44.179 |
| Income in Advance | 89.794 | - | - | 0 | 0 | 6.926 | 9.804 | 3.731 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2059 - 2059" | |||||||||
| CAEN Financial Year |
2059
|
|||||||||
Comments - Remed Prodimpex Srl